$ARM — Mixed Market Tape as Tech Outperformance Counters Big-cap Pharma Drop; Yields Tick Higher

0:00Welcome back to alpha recap, the stock alpha dot a i market rap. Glad you could join us. The market just closed and we've got a lot to unpack. As always, if you have questions, you can reach us at stock alpha dot a i. Thanks for having me big day, not a blowout one way or the other, but lots of interesting cross currents. Let's start with the headline. The S&P 500 closed down about 0.2%. The NASDAQ 100 rose about 0.6%. And the Russell 2000 was down about 0.9%. Nero leadership, right? Exactly. It was a classic day where large cap tech and a handful of other names carried the tape while smaller caps and some six or cause lagged. That disconnect is the story. So what really stands out here is that split tech strength versus health care pain and rising yields. Walk us through the internals first volume and breath were mixed. Large liquid NASDAQ names pushed indexes higher, amassed a lot of dispersion beneath the surface.

1:02Several single stock shocks moved entire sectors. Right, right. And the other thing is Novartis had a rough session. It plunged about 9% after trial setbacks. And that really dragged on health care and the S&P waiting. Yeah, that was the standard negative. When a big farmer name moves that hard, it can distort sector readings for the day. On the flip side, he let Packard enterprise jumped after company specific news and data center and cloud infrastructure names held up. That helped the NASDAQ 100 outpace the broader market. HP's move fed momentum into enterprise IT and hardware. The kind of trade that benefits when investors focus on AI infrastructure and cloud demand. And we saw some defense upgrades to Lockheed Martin got a lift after an upgrade tied to missile demand, which helped industrials and aerospace. Right, analysts noted secular defense spend and some supply chain normalization, a neat offset to the health care weakness for that sector. Short reaction.

2:03Short reaction. Right. Let's talk yields in the fed. Treasuries ticked higher today and that matters because higher yields compressed long duration growth multiples and tend to weigh on small caps. Exactly. Traders pushed yields up a bit from yesterday, not a runaway move, but enough to keep the market sensitive to fed timing. The takeaway markets haven't fully priced in an imminent pivot to cuts. I mean, you know, when you step back and look at this higher yields, plus single name shocks are a double headwind for small cap participation hence the Russell under performance. And that's important when small caps lag, it usually signals a lack of broad conviction behind a rally. It raises the risk of a sharper reversal with leadership stumbles. Okay, sector by sector technology led on the day driven by enterprise IT and data center names, but software sentiment was split. Communications was a mixed bag with some MNA optimism and add softness.

3:06Yet names with clear AI automation or cloud narratives outperformed advertising dependent stocks struggled in places where ad metrics disappointed. Healthcare was one of the clearest losers thanks to the Novartis job. That underscores how binary drug trials can be for market behavior. Analysts often remind clients drug development is an all or nothing business. A few disappointing readouts can wipe out a lot of near term value. Industrials and defense saw strength on upgrades and steady commentary. Utilities had pockets of momentum around storage and nuclear loan talk. Energy was mixed traditional oil faced pressure while electrification related materials drew buyers. Materials and mining built momentum likely because investors see them as commodity exposure and inflation hedges tied to electrification demand. Real estate was mixed data center reached it well, office and retail names remain

4:06under pressure. Retail and staples had their own headwinds after Kroger flagged margin and sales pressure. That fed caution into consumer names tied to inflation sensitivity. Yeah, honestly, I was a bit surprised by how much a single retailer call could ripple through staples today. Let's hit some notable individual moves. Novartis down about 9%, hewlett-packard enterprise rallied on positive news, Lockheed Martin outperformed after an upgrade, Kroger weighed on consumer sentiment and one data center company has been up about 1000% over five years. Big multi year rewriting there. That 1000% stat always grabs headlines. It's a reminder that concentrated winners can dominate index returns over multi year stretches. Short reaction. Yeah, absolutely. From a technical and trading perspective, the session reinforced narrow leadership. A handful of large cap names carried the market while breath stayed thin, raising the risk for sharper pullbacks if leaders consolidate.

5:09Right. When leadership is that concentrated, market technicians warn about the probability of volatility. You want to see small cap and sector breadth to confirm a durable move higher. So what are we watching next? The near term checklist first treasury yields in any fed commentary. Second, economic releases, inflation, payrolls, consumer data could push or pull the timeline for rate cuts. Third, company level catalyst earnings, trial readouts and follow-ons from today's Nevada shock. Fourth, flows into tech infrastructure and data center equities and finally developments in crypto and payments, institutional activity and payment network product rollouts can move that group. So analyst note, if inflation or payrolls print hotter than expected, that would likely favor cyclicals and make growth names more volatile. Noted. Yes, the market remains data dependent. Momentum indicates that cyclicals would benefit from hotter prints while

6:12long duration growth would face pressure. Quick reactions to takeaways in short form, narrow leadership, watch breadth, yield sensitivity, watch the 10 year and fed speak. Final thoughts, the bottom line, the market closed mixed with a neutral to cautious tilt. There were positive pockets, tech infrastructure, defense, materials, but health care shocks and slightly higher yields limited participation. Analysts note selective exposure may be how traders are positioning. And remember, this is informational market analysis. This isn't personalized advice. Analysts note the dynamics and possible outcomes, but this conversation isn't a recommendation to buy or sell any security key takeaways. S&P 500 closed down about 0.2%. NASDAQ 100 rose about 0.6%. Russell 2000 fell about 0.9%. Big pharma pain from Novartis, tech and data center strength, buoyed the NASDAQ 100 and treasury yields ticked higher, keeping rate

7:14sensitivity top of mind. That sums it up well. Keep an eye on macro prints and company catalysts next. If you have questions about anything we covered today, head to stock alpha dot AI, where you can ask us directly and we'll answer live. For more market analysis and insights, visit stock alpha dot AI. Thanks for listening. We'll be back after the next close.